JCN Newswire
TOKYO, May 21, 2025 – (JCN Newswire) – Eisai Co., Ltd. announced today the presentation of clinical research across its oncology portfolio and pipeline during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO25), which is taking place in Chicago, Illinois, and virtually,from May 30 to June 3.Notable data include findings from the Phase 3 LEAP-002 study…
Read More
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025
Elida Schewe
08:25
TOKYO, May 21, 2025 – (JCN Newswire) – Eisai Co., Ltd. announced today the presentation of clinical research across its oncology portfolio and pipeline during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO25), which is taking place in Chicago, Illinois, and virtually,from May 30 to June 3.Notable data include findings from the
